IRX Therapeutics, Inc.
Biotechnology company · New York, United States
IRX Therapeutics, Inc. is a biotechnology company headquartered in New York, United States. It has reported private securities offerings to the US SEC, most recently $33 million sold in a notice filed in 2017.
Profile compiled from public records. Is this your company? Request a correction or update
IRX Therapeutics at a glance
Typebiotechnology company
HeadquartersNew York, United States
SEC CIK1411920
What does IRX Therapeutics do?
Private fundraising reported to the SEC
10 Form D notices; the most recent reported $33.2 million sold (2017).
Frequently asked questions about IRX Therapeutics
Where is IRX Therapeutics headquartered?
IRX Therapeutics, Inc. is headquartered in New York, United States.
What does IRX Therapeutics do?
IRX Therapeutics, Inc. is a biotechnology company.
Similar companies
- Lexeo Therapeutics, Inc.New York City, New York, United States
- MiNK Therapeutics, Inc.New York City, New York, United States
- IN8BIO, Inc.New York City, New York, United States
- Anavex Life Sciences Corp.New York City, New York, United States
- Brainstorm Cell Therapeutics Inc.New York City, New York, United States
- Bioincept LLCNew York City, New York, United States
- Protara Therapeutics, Inc.New York City, New York, United States
- Ancilia Biosciences, Inc.New York City, New York, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences